Tuberculosis & HIV: Research
- Clinical Pharmacology at CROI 2013 (April 4, 2013)
From National AIDS Treatment Advocacy Project
- Researchers Discuss Advances in Tuberculosis Treatment (March 11, 2013)
From HIVandHepatitis.com
- Higher Dose of Rifampin Seems Safe in TB (March 7, 2013)
From MedPage Today
- Weekly Therapy Matches TB Care Standard (March 7, 2013)
From MedPage Today
- Dosing of Key TB Drug Rifampicin Could Go Higher (March 7, 2013)
From aidsmap.com
- Once-Weekly Continuation Phase TB Treatment Equals Standard of Care (March 7, 2013)
From aidsmap.com
- Pediatric TB/HIV Coinfection: Glimpses of Pharmacokinetic Data and a Potential New Approach to Drug Development (January/February 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Risk of TB Among HIV-Positive People in High-Income Countries (December 13, 2012)
In CATIE News, from Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- Experimental Nitroimidazole TBA-354 Shows Promise Against Tuberculosis in Early Studies (September 11, 2012)
From HIVandHepatitis.com
- Colliding Epidemics: HIV, TB and Other Diseases (August 2, 2012)
From AIDSmeds.com
- Raltegravir 800 mg Twice Daily Appears a Good Alternative to Efavirenz for HIV-TB Treatment (July 31, 2012)
From aidsmap.com
- 2012 Pipeline Report: HIV, Hepatitis C Virus (HCV) and Tuberculosis Drugs, Diagnostics, Vaccines and Preventive Technologies in Development (PDF) (July 2012)
From HIV i-Base and Treatment Action Group
On TheBodyPRO.com
- HIV i-Base/Treatment Action Group 2012 Pipeline Report Reveals Deep Gaps Between Scientific Promise and Program Delivery (July 21, 2012)
Recent advances in biomedical HIV, hepatitis C virus (HCV) and tuberculosis (TB) prevention and treatment are not reaching those who need them most; political leaders continue to break domestic, global health commitments.
From HIV i-Base and Treatment Action Group
On TheBodyPRO.com
- CDC Grand Rounds: The TB/HIV Syndemic (July 6, 2012)
To read PDF, click here.
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Low CD4 Cell Count and Older Age Associated With Increased Risk of TB After Starting HIV Therapy (April 11, 2012)
From aidsmap.com
- Treating TB, HIV Co-Infections Early, Aggressively Can Save Lives, Multiple Studies Show (October 20, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- 2011 Pipeline Report: HIV, Hepatitis C Virus (HCV), and Tuberculosis Drugs, Diagnostics, Vaccines, and Preventive Technologies in Development (PDF) (September 2011)
From Treatment Action Group
- Lopinavir and Rifampicin Interaction in HIV-Positive Patients (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Lopinavir/r Reduces Levels of Rifabutin (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Formulations of Anti-TB Medications (May/June 2011)
In HIV Treatment Bulletin, from HIV i-Base
- Drug Resistance Hampers Fight Against Tuberculosis (March 22, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
|
Advertisement
|
Email
Glossary
